Clinical Trials Logo

Generalized Anxiety Disorder clinical trials

View clinical trials related to Generalized Anxiety Disorder.

Filter by:

NCT ID: NCT01912287 Completed - Clinical trials for Generalized Anxiety Disorder

GATE: Generalized Anxiety - A Treatment Evaluation

Start date: December 2013
Phase: N/A
Study type: Interventional

The purpose of this randomized study is to examine the comparative efficacy of yoga, cognitive behavioral therapy, and stress education, a previously employed control condition, for patients with Generalized Anxiety Disorder.

NCT ID: NCT01844115 Completed - Clinical trials for Generalized Anxiety Disorder

Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder

Start date: April 30, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD).

NCT ID: NCT01766401 Completed - Clinical trials for Generalized Anxiety Disorder

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

VLZ-MD-06
Start date: January 31, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD).

NCT ID: NCT01702220 Completed - Clinical trials for Generalized Anxiety Disorder

Calmer Life: Testing the Effectiveness of a Treatment for Anxiety

Start date: October 2012
Phase: N/A
Study type: Interventional

The overall goals of the proposed research study are to: (1) examine quantitative outcomes in a well-conducted randomized clinical trial of Calmer Life, relative to Enhanced Community Care, an information and referral intervention that represents care in a real-world community-service environment, and (2) evaluate implementation feasibility, which includes training community providers; examining program reach, engagement, acceptability, and barriers-facilitators; and preparing practical tools for replicating the program.

NCT ID: NCT01681329 Completed - Clinical trials for Generalized Anxiety Disorder

Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder

CBT+IMT-GAD
Start date: September 2012
Phase: N/A
Study type: Interventional

Generalized Anxiety Disorder (GAD) is a condition characterized by chronic and excessive worry and anxiety. Our group has developed a cognitive-behavioural treatment (CBT) for GAD that has been tested in four previous clinical trials. The findings show that 60 to 70% of affected individuals attain GAD remission and that 50 to 55% achieve high endstate functioning following the treatment. Although these numbers are encouraging, there remain a considerable proportion of individuals who do not fully benefit from treatment. In our most recent CIHR-funded treatment study, we assessed the impact of information processing on the efficacy of CBT for GAD. Our findings show: a) that the tendency to negatively interpret ambiguous information at pre-treatment was associated with greater GAD symptoms at post-treatment; and b) that patients who were less successful at changing their negative interpretation style were also less responsive to CBT. Given that computerized interpretation modification training has been shown to be effective for decreasing the negative interpretation style of anxious individuals, the goal of the current proposal is to determine whether such training can augment the efficacy of CBT for adults with GAD. A total of 138 individuals with a primary diagnosis of GAD will be randomly allocated to one of two conditions: a) CBT plus interpretation modification training or b) CBT plus non-active training. CBT will consist of 14 weekly sessions, with interpretation modification training (or non-active training) administered prior to each session. Measures of GAD symptoms, psychopathology, cognitive vulnerability, and interpretation style will be administered at pre-, mid-, and post-treatment, as well as at 6- and 12-month follow-ups. The proposed study will provide information about the efficacy, clinical usefulness, and mechanisms of interpretation modification training in combination with CBT.

NCT ID: NCT01659736 Completed - Clinical trials for Generalized Anxiety Disorder

Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder

Start date: May 2012
Phase: N/A
Study type: Interventional

This study is investigating a new indication of Transcranial Magnetic Stimulation (TMS) by conducting a pilot randomized-controlled trial (RCT) comparing structural neuronavigation-directed TMS to Sham-TMS Placebo therapy for treatment of Generalized Anxiety Disorder (GAD).

NCT ID: NCT01629966 Completed - Clinical trials for Generalized Anxiety Disorder

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

VLZ-MD-05
Start date: June 30, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD)

NCT ID: NCT01614041 Completed - Clinical trials for Generalized Anxiety Disorder

Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder

TACGAD
Start date: January 10, 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of comparative high dose Tandospirone Citrate in the treatment of patients with generalized anxiety disorder.

NCT ID: NCT01607710 Completed - Clinical trials for Generalized Anxiety Disorder

Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)

fMRI
Start date: July 2012
Phase: N/A
Study type: Observational

The investigators are seeking to locate the brain regions of interest in generalized anxiety disorder (GAD) using both structural (sMRI) and functional magnetic resonance imaging (fMRI). The MRI will be used to measure changes in blood flow in the brain while at rest and while completing tasks designed to elicit symptoms of anxiety. Results from a nonclinical control group and a GAD group will be compared to determine whether they exhibit different areas of brain activity during the tasks.

NCT ID: NCT01570374 Completed - Clinical trials for Generalized Anxiety Disorder

Internet-based Treatment of Generalized Anxiety Disorder

Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether internet-administered cognitive behavior therapy is a feasible treatment for generalized anxiety disorder.